A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine
Clinical trial NCT04575181 · COMPLETED
Trial details
- NCT number
- NCT04575181
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2021-12-10
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.